{"id":"https://openalex.org/W1543476112","doi":"https://doi.org/10.1158/1538-7445.sabcs14-pd4-2","title":"Abstract PD4-2: Cardiovascular toxicity following aromatase inhibitor use in 13,273 survivors cared for in a HMO","display_name":"Abstract PD4-2: Cardiovascular toxicity following aromatase inhibitor use in 13,273 survivors cared for in a HMO","publication_year":2015,"publication_date":"2015-05-01","ids":{"openalex":"https://openalex.org/W1543476112","doi":"https://doi.org/10.1158/1538-7445.sabcs14-pd4-2","mag":"1543476112"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs14-pd4-2","doi":"https://doi.org/10.1158/1538-7445.sabcs14-pd4-2","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs14-pd4-2","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069743065","display_name":"Reina Haque","orcid":"https://orcid.org/0000-0001-8563-3330","observed_orcids":["https://orcid.org/0000-0001-8563-3330"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reina Haque","raw_affiliation_strings":["1Kaiser Permanente Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kaiser Permanente Southern California","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013280766","display_name":"Joanne E. Schottinger","orcid":"https://orcid.org/0000-0002-8276-7672","observed_orcids":["https://orcid.org/0000-0002-8276-7672"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne E Schottinger","raw_affiliation_strings":["1Kaiser Permanente Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kaiser Permanente Southern California","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053770947","display_name":"Jiaxiao M. Shi","orcid":"https://orcid.org/0000-0001-8397-3729","observed_orcids":["https://orcid.org/0000-0001-8397-3729"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiaxiao Shi","raw_affiliation_strings":["1Kaiser Permanente Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kaiser Permanente Southern California","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110558903","display_name":"Joanie Chung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanie Chung","raw_affiliation_strings":["1Kaiser Permanente Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kaiser Permanente Southern California","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059426745","display_name":"Chantal C Avila","orcid":"https://orcid.org/0000-0003-1753-5549","observed_orcids":["https://orcid.org/0000-0003-1753-5549"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chantal Avila","raw_affiliation_strings":["1Kaiser Permanente Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kaiser Permanente Southern California","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063925160","display_name":"Britta I. Amundsen","orcid":"https://orcid.org/0009-0007-6301-1611","observed_orcids":["https://orcid.org/0009-0007-6301-1611"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Britta Amundsen","raw_affiliation_strings":["1Kaiser Permanente Southern California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kaiser Permanente Southern California","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004840750","display_name":"Rowan T. Chlebowski","orcid":"https://orcid.org/0000-0002-4212-6184","observed_orcids":["https://orcid.org/0000-0002-4212-6184"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rowan T Chlebowski","raw_affiliation_strings":["2Los Angeles BioMedical Research Institute at the Harbor-UCLA Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Los Angeles BioMedical Research Institute at the Harbor-UCLA Medical Center","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210165985"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"9_Supplement","first_page":"PD4","last_page":"2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.4494999945163727,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.4494999945163727,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.1703999936580658,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.07240000367164612,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/breast-cancer-survivors","display_name":"breast cancer survivors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.871999979019165},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/ischemic-heart-disease","display_name":"ischemic heart disease","score":0.7850000262260437},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9509999752044678},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cardiomyopathy","display_name":"cardiomyopathy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cardiac-arrhythmia","display_name":"cardiac arrhythmias","score":0.7889999747276306},{"id":"https://openalex.org/keywords/valvular-dysfunction","display_name":"valvular dysfunction","score":0.9269999861717224},{"id":"https://openalex.org/keywords/pericarditis","display_name":"pericarditis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/sequential-endocrine-therapy","display_name":"sequential endocrine therapy","score":0.6000000238418579},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5609999895095825},{"id":"https://openalex.org/keywords/breast-cancer-prevention-trial","display_name":"Breast Cancer Prevention Trial","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9399945735931396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6408055424690247},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.576336145401001},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.5547948479652405},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5448567271232605},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5142952799797058},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48626744747161865},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.4646906852722168},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.44996920228004456},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.09758290648460388}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs14-pd4-2","doi":"https://doi.org/10.1158/1538-7445.sabcs14-pd4-2","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs14-pd4-2","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1994860548","https://openalex.org/W3180231141","https://openalex.org/W2339873281","https://openalex.org/W3109566719","https://openalex.org/W4411234303","https://openalex.org/W7026947782","https://openalex.org/W3019777750","https://openalex.org/W4319002809","https://openalex.org/W7204940336","https://openalex.org/W2063374686"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Aromatase":[2],"inhibitors":[3],"(AIs)":[4],"reduce":[5],"breast":[6,47,299,337,350,379,431],"cancer":[7,48,126,380],"incidence":[8],"in":[9,36,56,226,370,378,384,401,416,478,483],"primary":[10],"prevention":[11,37],"trials":[12],"(MAP3,":[13],"IBIS2).":[14],"However,":[15,169,410],"controversy":[16],"regarding":[17],"AI\u2019s":[18],"influence":[19],"on":[20,86,221,291],"cardiovascular":[21],"disease":[22,150,182,205,395],"(MI,":[23],"angina,":[24],"and":[25,66,92,97,122,130,155,214,235,314,326,449],"cardiac":[26],"failure)":[27],"(Amir":[28],"et":[29],"al":[30],"JNCI":[31],"2011)":[32],"could":[33],"limit":[34],"use":[35,115,477],"settings.":[38],"Methods":[39],"We":[40,107],"assembled":[41],"a":[42,57,145,176,292,443,484],"cohort":[43],"of":[44,148,179,202,229,294,303,373,393,451,489],"13,273":[45,136,479],"postmenopausal":[46,138],"patients":[49,296,381],"initially":[50],"CVD":[51,72,99,123,181,204,223,304,374,412],"(cardiovascular":[52],"disease)-free":[53],"at":[54],"diagnosis":[55],"large":[58],"managed":[59],"care":[60],"organization.":[61],"Women":[62],"were":[63,101,414],"diagnosed":[64],"1991-2010,":[65],"followed":[67],"through":[68],"2012.":[69],"The":[70,200,217],"outcome,":[71],"risk":[73,147,178,201,302,392],"was":[74,206,306,398],"compared":[75],"across":[76],"endocrine":[77,113,452],"treatments":[78],"(AI,":[79],"tamoxifen":[80,387],"[TAM],":[81],"both,":[82],"or":[83,396],"neither).":[84],"Information":[85],"demographics,":[87,120],"comorbidity":[88],"(diabetes,":[89],"hypertension,":[90],"etc.),":[91],"covariate":[93],"medications":[94],"(antihyperlipidemics,":[95],"antihypertensives,":[96],"other":[98,180,203],"drugs)":[100],"available":[102],"from":[103],"electronic":[104],"medical":[105],"records.":[106],"conducted":[108],"Cox":[109],"models":[110],"using":[111],"time-dependent":[112],"drug":[114,124],"variables":[116],"adjusted":[117],"for":[118,445,482],"age,":[119],"comorbidity,":[121],"use,":[125],"treatment,":[127],"tumor":[128,131],"characteristics":[129],"laterality.":[132],"Results":[133],"Among":[134],"the":[135,301,371,391,447,490],"cohort,":[137],"women":[139,170,209,309,417],"who":[140,163,171,297,310,403,418],"used":[141,164,172,311,404,419],"AIs":[142,173,312,383,405,420],"exclusively":[143],"had":[144,175],"similar":[146],"ischemic":[149,394],"(HR=0.97,":[151,157],"95%":[152,158,191,319],"CI:":[153,159,192,320],"0.78-1.22)":[154],"stroke":[156,397],"0.70-1.33)":[160],"versus":[161,407],"those":[162,195,402],"TAM":[165,198,213,408],"only":[166,174,313,406,421],"(HR=1.00,":[167],"reference).":[168],"higher":[177],"combined":[183],"(CHF,":[184],"cardiomyopathy,":[185],"dysrthymia,":[186],"valvular":[187],"dysfunction,":[188],"pericarditis)":[189],"(HR=1.26,":[190],"1.11-1.43)":[193],"than":[194],"exposed":[196,210],"to":[197,211,386],"only.":[199],"greater":[207,307,415],"among":[208,308],"sequential":[212],"AI":[215],"treatment.":[216],"results":[218,365,437],"are":[219],"based":[220],"3,711":[222],"events":[224,375,413],"occurring":[225],"72,886":[227],"woman-years":[228],"follow-up.":[230],"Tamoxifen":[231,322],"OnlyAI":[232,323],"OnlyBoth":[233,324],"Tam":[234,325],"AINo":[236,327],"HormonesHR":[237,328],"(95%":[238,240,242,244,329,331,333,335],"Cl)HR":[239,241,243,330,332,334],"Cl)MUTUALLY":[245],"EXCLUSIVE":[246],"CATEGORIESIschemic1.00":[247],"(ref)0.97":[248,258],"(0.78":[249],"-":[250,253,256,260,263,266,271,274,277,282,285,288,342,345,348,355,358,361],"1.22)1.04":[251],"(0.83":[252],"1.29)1.02":[254],"(0.84":[255],"1.23)Stroke1.00":[257],"(0.70":[259,265],"1.33)1.02":[261],"(0.75":[262],"1.37)0.93":[264],"1.24)Other":[267],"CVD1.00":[268,279,339,352],"(ref)1.26":[269],"(1.11":[270],"1.43)1.28":[272],"(1.13":[273],"1.44)1.23":[275],"(1.09":[276],"1.38)COMPOSITE":[278],"(ref)1.15":[280],"(1.04":[281,287,344],"1.28)1.19":[283],"(1.07":[284],"1.31)1.14":[286],"1.25)":[289],"Based":[290],"subset":[293],"7,982":[295],"underwent":[298],"irradiation,":[300],"overall":[305,411],"received":[315,429],"left-sided":[316,430],"irradiation":[317],"(HR=1.21,":[318],"1.02-1.44).":[321],"Cl)Right-sided":[336],"irradiationCOMPOSITE":[338,351],"(ref)1.16":[340],"(1.00":[341],"1.34)1.20":[343],"1.38)1.08":[346],"(0.95":[347],"1.23)Left-sided":[349],"(ref)1.21":[353],"(1.02":[354],"1.44)1.16":[356],"(0.98":[357],"1.37)1.14":[359],"(0.93":[360],"1.40)":[362],"Discussion":[363],"These":[364],"indicate":[366],"that":[367,376],"variation":[368],"exists":[369],"type":[372],"occur":[377],"receiving":[382],"comparison":[385],"users.":[388,409],"For":[389],"example,":[390],"not":[399],"elevated":[400],"(or":[422],"sequentially":[423],"after":[424],"TAM),":[425],"especially":[426],"if":[427],"they":[428,441],"irradiation.":[432],"While":[433],"these":[434],"observational":[435],"study":[436],"require":[438],"cautious":[439],"interpretation,":[440],"provide":[442],"basis":[444],"comparing":[446],"benefits":[448],"risks":[450],"treatments.":[453],"Citation":[454],"Format:":[455],"Reina":[456],"Haque,":[457],"Joanne":[458],"E":[459],"Schottinger,":[460],"Jiaxiao":[461],"Shi,":[462],"Joanie":[463],"Chung,":[464],"Chantal":[465],"Avila,":[466],"Britta":[467],"Amundsen,":[468],"Rowan":[469],"T":[470],"Chlebowski.":[471],"Cardiovascular":[472],"toxicity":[473],"following":[474],"aromatase":[475],"inhibitor":[476],"survivors":[480],"cared":[481],"HMO":[485],"[abstract].":[486],"In:":[487],"Proceedings":[488],"Thirty-Seventh":[491],"Annual":[492],"CTRC-AACR":[493],"San":[494,502],"Antonio":[495],"Breast":[496],"Cancer":[497,508],"Symposium:":[498],"2014":[499],"Dec":[500],"9-13;":[501],"Antonio,":[503],"TX.":[504],"Philadelphia":[505],"(PA):":[506],"AACR;":[507],"Res":[509],"2015;75(9":[510],"Suppl):Abstract":[511],"nr":[512],"PD4-2.":[513]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2016-06-24T00:00:00"}